Several studies have suggested that COVID-19 may increase a person’s risk of developing cancer or promote metastasis of existing cancer.
Last month, Teddi Mellencamp revealed a multiple brain tumor diagnosis after doctors investigated her sudden, severe ...
Adding immunotherapy to a new type of inhibitor that targets multiple forms of the cancer-causing gene mutation KRAS kept ...
GlobalData on MSN1d
BioCity and MSD to evaluate cancer treatment combination in Phase I/II trialBioCity Biopharmaceuticals and MSD have signed a clinical trial partnership agreement to assess BC3195 in conjunction with ...
VERITAC-2 achieved its primary endpoint in the estrogen receptor 1-mutant population, demonstrating statistically significant and clinically meaningful ...
Biotherapeutics announced promising preclinical results for its systemic RTNova platform. The platform has successfully delivered ...
The RTNova platform addresses the challenges of treating advanced-stage metastatic cancers, including lung cancer, when intratumoral administration is not feasible. Calidi designed an innovative ...
The Renaissance Center has a history of asbestos, and tearing down two of the skyscrapers could prove challenging and costly, ...
Coherus BioSciences, Inc. ( NASDAQ: CHRS) Q4 2024 Earnings Conference Call March 10, 2025 5:00 PM ET Jodi Sievers - Head of IR Denny Lanfear - CEO Paul Reider - CCO Sameer Goregaoker - SVP, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback